Assignee
RIBOZYME PHARM INC
US·109 granted patents·18 pending applications·10,873 citations·filing 1992–2003
Top patents by PatentIndex Score
127 records- 0199US5627053A2'deoxy-2'-alkylnucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 1995·Granted May 6, 1997·1.5k cites·5 claims
- 0298US6362323B1Non-nucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 2000·Granted Mar 26, 2002·179 cites·7 claims
- 0398US6117657ANon-nucleotide containing enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1998·Granted Sep 12, 2000·253 cites·13 claims
- 0498US5998203AEnzymatic nucleic acids containing 5'-and/or 3'-cap structuresRIBOZYME PHARM INC·Filed 1996·Granted Dec 7, 1999·784 cites·41 claims
- 0598US5972704AHIV nef targeted ribozymesRIBOZYME PHARM INC·Filed 1997·Granted Oct 26, 1999·221 cites·22 claims
- 0698US5869253AMethod and reagent for inhibiting hepatitis C virus replicationRIBOZYME PHARM INC·Filed 1996·Granted Feb 9, 1999·226 cites·22 claims
- 0798US5716824A2'-O-alkylthioalkyl and 2-C-alkylthioalkyl-containing enzymatic nucleic acids (ribozymes)RIBOZYME PHARM INC·Filed 1995·Granted Feb 10, 1998·373 cites·12 claims
- 0897US6602858B2Nucleic acid catalysts comprising L-nucleotide analogsRIBOZYME PHARM INC·Filed 2001·Granted Aug 5, 2003·68 cites·23 claims
- 0997US6395713B1Compositions for the delivery of negatively charged moleculesRIBOZYME PHARM INC·Filed 1998·Granted May 28, 2002·367 cites·13 claims
- 1097US6303773B1Deprotection of RNARIBOZYME PHARM INC·Filed 2000·Granted Oct 16, 2001·150 cites·20 claims
- 1197US6248878B1Nucleoside analogsRIBOZYME PHARM INC·Filed 1997·Granted Jun 19, 2001·264 cites·16 claims
- 1297US6146886ARNA polymerase III-based expression of therapeutic RNAsRIBOZYME PHARM INC·Filed 1995·Granted Nov 14, 2000·200 cites·21 claims
- 1397US5831071ASynthesis deprotection analysis and purification of RNA and ribozymesRIBOZYME PHARM INC·Filed 1997·Granted Nov 3, 1998·197 cites·2 claims
- 1497US5610054AEnzymatic RNA molecule targeted against Hepatitis C virusRIBOZYME PHARM INC·Filed 1994·Granted Mar 11, 1997·165 cites·16 claims
- 1596US6566127B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorRIBOZYME PHARM INC·Filed 1999·Granted May 20, 2003·141 cites·5 claims
- 1696US6528640B1Synthetic ribonucleic acids with RNAse activityRIBOZYME PHARM INC·Filed 1999·Granted Mar 4, 2003·283 cites·3 claims
- 1796US6469158B1Synthesis, deprotection, analysis and purification of RNA and ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Oct 22, 2002·205 cites·17 claims
- 1896US6353098B1Synthesis, deprotection, analysis and purification of RNA and ribozymesRIBOZYME PHARM INC·Filed 1998·Granted Mar 5, 2002·191 cites·22 claims
- 1996US6346398B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorRIBOZYME PHARM INC·Filed 1996·Granted Feb 12, 2002·245 cites·23 claims
- 2096US5804683ADeprotection of RNA with alkylamineRIBOZYME PHARM INC·Filed 1995·Granted Sep 8, 1998·235 cites·1 claims
- 2196US5631360AN-phthaloyl-protected 2'-amino-nucleoside phosphoramditesRIBOZYME PHARM INC·Filed 1995·Granted May 20, 1997·157 cites·16 claims
- 2295US6437117B1Synthesis, deprotection, analysis and purification for RNA and ribozymesRIBOZYME PHARM INC·Filed 1999·Granted Aug 20, 2002·187 cites·16 claims
- 2395US6159951A2'-O-amino-containing nucleoside analogs and polynucleotidesRIBOZYME PHARM INC·Filed 1997·Granted Dec 12, 2000·136 cites·18 claims
- 2495US5902880ARNA polymerase III-based expression of therapeutic RNAsRIBOZYME PHARM INC·Filed 1994·Granted May 11, 1999·308 cites·24 claims
- 2595US5877022ARibozymes targeted to APO(a) RNARIBOZYME PHARM INC·Filed 1996·Granted Mar 2, 1999·167 cites·20 claims
- 2695US5631359AHairpin ribozymesRIBOZYME PHARM INC·Filed 1994·Granted May 20, 1997·268 cites·15 claims
- 2794US6054576ADeprotection of RNARIBOZYME PHARM INC·Filed 1998·Granted Apr 25, 2000·153 cites·17 claims
- 2893US6162909ADeprotection of RNARIBOZYME PHARM INC·Filed 1999·Granted Dec 19, 2000·130 cites·19 claims
- 2993US5646042AC-myb targeted ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Jul 8, 1997·123 cites·220 claims
- 3092US6251666B1Nucleic acid catalysts comprising L-nucleotide analogsRIBOZYME PHARM INC·Filed 1998·Granted Jun 26, 2001·121 cites·30 claims
- 3192US5583020APermeability enhancers for negatively charged polynucleotidesRIBOZYME PHARM INC·Filed 1993·Granted Dec 10, 1996·318 cites·30 claims
- 3291US6127173ANucleic acid catalysts with endonuclease activityRIBOZYME PHARM INC·Filed 1998·Granted Oct 3, 2000·194 cites·28 claims
- 3391US5891683ANon-nucleotide containing enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1994·Granted Apr 6, 1999·104 cites·16 claims
- 3491US5877021AB7-1 targeted ribozymesRIBOZYME PHARM INC·Filed 1996·Granted Mar 2, 1999·88 cites·11 claims
- 3590US5985621A2'-deoxy-2'-alkylnucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 1996·Granted Nov 16, 1999·63 cites·12 claims
- 3690US5891684ABase-modified enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1994·Granted Apr 6, 1999·91 cites·38 claims
- 3789US5525468AAssay for Ribozyme target siteRIBOZYME PHARM INC·Filed 1994·Granted Jun 11, 1996·122 cites·15 claims
- 3887US6350934B1Nucleic acid encoding delta-9 desaturaseRIBOZYME PHARM INC·Filed 1996·Granted Feb 26, 2002·89 cites·11 claims
- 3987US6183959B1Method for target site selection and discoveryRIBOZYME PHARM INC·Filed 1998·Granted Feb 6, 2001·57 cites·48 claims
- 4087US5811300ATNF-α ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Sep 22, 1998·95 cites·13 claims
- 4186US5972699AMethod and reagent for inhibiting herpes simplex virus replicationRIBOZYME PHARM INC·Filed 1997·Granted Oct 26, 1999·53 cites·21 claims
- 4286US5496698AMethod of isolating ribozyme targetsRIBOZYME PHARM INC·Filed 1992·Granted Mar 5, 1996·132 cites·18 claims
- 4385US6410224B1Ribozyme treatment of diseases or conditions related to levels of NF-κBRIBOZYME PHARM INC·Filed 1996·Granted Jun 25, 2002·48 cites·4 claims
- 4485US6017756AMethod and reagent for inhibiting hepatitis B virus replicationRIBOZYME PHARM INC·Filed 1994·Granted Jan 25, 2000·79 cites·6 claims
- 4585US5731295AMethod of reducing stromelysin RNA via ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Mar 24, 1998·59 cites·2 claims
- 4685US5693535AHIV targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Dec 2, 1997·84 cites·100 claims
- 4784US5989906AMethod and reagent for inhibiting P-glycoprotein (mdr-1-gene)RIBOZYME PHARM INC·Filed 1994·Granted Nov 23, 1999·62 cites·6 claims
- 4884US5861288ACatalytic DNARIBOZYME PHARM INC·Filed 1993·Granted Jan 19, 1999·87 cites·15 claims
- 4983US6586238B1Enzymatic nucleic acids containing 5′-and or 3′-cap structuresRIBOZYME PHARM INC·Filed 1999·Granted Jul 1, 2003·43 cites·20 claims
- 5083US6489465B2Xylofuranosly-containing nucleoside phosphoramidites and polynucleotidesRIBOZYME PHARM INC·Filed 2001·Granted Dec 3, 2002·7 cites·20 claims
Showing the top 50 of 127 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when RIBOZYME PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →